WVP
GRTX

Worth Venture Partners’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Worth Venture Partners’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-472,180
Closed -$3.83M – 154
2021
Q3 		$3.83M Buy
472,180
+3,006
+0.6% +$25.8K 1.72% 16
2021
Q2 		$4.61M Buy
469,174
+254,932
+119% +$2.07M 1.72% 17
2021
Q1 		$1.89M Buy
+214,242
New +$2.35M 0.92% 33

Other funds holding GRTX

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Worth Venture Partners's GRTX Position: Q4 2021 in Review

Worth Venture Partners sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2021, closing a stake of 472,180 shares — an estimated $3.83M sold.

Worth Venture Partners first reported a position in GRTX in Q1 2021 and held it in 3 quarters. The position peaked at $4.61M in Q2 2021. 44 funds tracked by Wall St. Rank hold GRTX as of Q4 2021.

  • Worth Venture Partners reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Worth Venture Partners sold 472,180 Galera Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $3.83M.
  • Worth Venture Partners first reported a position in Galera Therapeutics, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Worth Venture Partners's Galera Therapeutics, Inc. Common Stock position peaked at $4.61M in Q2 2021.
  • 44 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Worth Venture Partners's 13F filing for Q4 2021, filed 14 Feb 2022.